Davao’s iodized salt brands fail iodine tests, FDA issues warnings

Several popular iodized salt brands in the Davao region have failed to meet required iodine levels. Testing in 2024 and early 2025 revealed some products contained too little or too much iodine. The Food and Drug Administration (FDA) has since issued warnings to non-compliant manufacturers.

Under Republic Act 8172, iodized salt must contain 30-70 parts per million (ppm) of iodine. At least 15 ppm should remain by the time it reaches households. The FDA regularly inspects production facilities to check compliance with these standards.

Two manufacturers currently operate in the Davao region. One has met the requirements, while the other awaits inspection. The FDA does not immediately shut down non-compliant producers. Instead, they receive notices of violation and health advisories, giving them time to correct issues.

The agency also monitors certificates of product registration (CPR) and licences to operate (LTO) for manufacturers, distributors, and repackers. Consumers can check salt labels or use the FDA’s online verification portal to confirm compliance.

The FDA 11 has reminded all salt producers, importers, and sellers to follow iodine content rules. Non-compliant brands face further action if they fail to adjust their products. The agency continues to enforce standards to ensure safe and properly fortified salt reaches consumers.